Biosyn is developing a patented broad-spectrum anti-infective compound known as C31G. This compound displays activity against gram positive and ...ssss
0.5% C31G oral rinse is a unique product for management of oral infections associated with immune-suppression. Patients with diseases or chronic...ssss
Biosyn is developing a dermatologic product for treatment of mixed, multiple-resistant superficial skin infections. The dermatologic program is ...ssss